Spago Nanomedical Gets SpagoPix Abstract Accepted at Breast Cancer Conference
| Date | 21st, Sep 2022 |
|---|---|
| Source | AZoNano - Nanotechnology Websites |
DESCRIPTION
Spago Nanomedical AB (publ) today announced that an abstract, concluding the initial results from the First-In-Human Phase I clinical trial SPAGOPIX-01, has been accepted for poster presentation at the 2022 San Antonio Breast Cancer Symposium® (SABCS) on December 6-10, 2022.